Grantopen🌐 United StatesPAR-25-145
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
National Institutes of Health
Summary?
National Institutes of Health has posted an open Grant: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional). It falls under 93.393. Responses are due January 7, 2028.
Details?
- Posted
- Nov 6, 2024
- Response deadline
- Jan 7, 2028, 12:00 AM UTC (531d)
- Type
- Grant
- Category
- 93.393
- Status
- open
- Buyer
- National Institutes of Health
- Department
- HHS-NIH11
- Jurisdiction
- United States
- Reference #
- PAR-25-145
- Has Description
- false
- Doc Type
- synopsis
- Opp Status
- posted
Finding similar opportunities…
This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.